4-AcO-DMT Facts
Psychedelic;
Description
4-AcO-DMT (O-acetylpsilocin) — also known as psilacetin — is a synthetic psychedelic of the tryptamine class. It activates serotonin receptors in the brain, producing the visual and cognitive shifts of classical psychedelics.[1][2]
Subjective effects include geometric visual patterns, brightened colors, emotional deepening, introspection enhancement, and ego dissolution at high doses. The experience is warm and body-centered — widely described as indistinguishable from psilocybin mushrooms,[3] and less stimulating than LSD.
4-AcO-DMT produces no physical dependence, and a single dose causes rapid tolerance that makes compulsive use unlikely.[4] The primary danger is psychological — high doses can produce panic, paranoia, and identity disruption, and combining it with serotonin-raising drugs risks a dangerous overactivation of the serotonin system.
Dose and durationby route · individual sensitivity varies
Starts in 15 – 40 minLasts 4 – 7 hoursAfter-effects 4 – 48 hours
Body and dependence
- Acute toxicity
- Low
- Chronic toxicity
- Low
- Physical dependence
- None
- Psychological dependence
- Negligible
- Withdrawal
- None recorded
- Compulsive redosing
- Negligible
Tolerance
- Builds
- Rapid
- Fully resets after
- 7 days
- Carries over to
- psilocybin;
psilocin; LSD; DMT; mescaline
Effectslikely at a common dose
- Perception
- Music enhancement;
Color enhancement; Visual drifting; Color alteration; Geometry; Visual breathing; Holotropic state; +30 possible, including Visual haze / noise, Spatial disorientation, Vestibular distortion - Body
- Pupil dilation;
Body high; +34 possible, including Nausea, Insomnia, Temperature dysregulation - Thinking
- Introspection enhancement;
+32 possible, including Language suppression, Memory suppression, Thought loops - Feeling
- Emotional enhancement;
+8 possible, including Anxiety, Emotional lability, Paranoia - Self
- none likely · 11 possible, including Derealization, Depersonalization, Ego inflation
- Time
- Time alteration;
+4 possible, including Temporal disorientation - Transpersonal
- none likely · 1 possible
- Awareness
- Personal insight;
+3 possible
Who shouldn't take it
Combinations61 recorded
Seek help immediately if
Most difficulty is psychological (intense fear, panic, confusion) and passes with calm support — the signs below mean seek emergency help:
- Very high body temperature; hot, dry skin
- Seizures
- Chest pain; fast or irregular heartbeat
- Severe muscle rigidity, tremor, or twitching (possible serotonin syndrome)
- Cold, pale, or blue fingers/toes — severe vasoconstriction (notably NBOMe / DOx)
- Persistent vomiting; unconsciousness; uncontrollable agitation or risk of self-harm
What to do
- Stay calm and reassure — remind them they took a drug and the effect will pass
- Move to a calm, quiet, safe space with low light; reduce noise and sensory input
- Keep them from harm — they may act on fear or confusion; stay with them, don't leave them alone
- Talk them down gently; don't grab or restrain unless they're in danger
- For the medical signs above (overheating, seizure, chest pain, vasoconstriction, unresponsive) call emergency services
- If overheating, cool the body; be ready to give rescue breaths / CPR
The experience is time-limited and usually resolves with calm reassurance in a safe setting — psychological first aid, not medication. Serious physical harm is uncommon for classic psychedelics (LSD, psilocybin) but real for some potent phenethylamines (NBOMe, DOx), where hyperthermia, seizures, and vasoconstriction warrant emergency care.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Glatfelter GC, Pottie E, Partilla JS, Sherwood AM, et al. (2022) Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice — ACS Pharmacology and Translational Science doi:10.1021/acsptsci.2c00177
- [2]^Zhai W, Li L, Zhao J, Xiang P, Liu M, Shi Y, Dang Y (2022) Tentative identification of in vitro metabolites of O-acetylpsilocin (psilacetin, 4-AcO-DMT) by UHPLC-Q-Orbitrap MS — Drug Testing and Analysis doi:10.1002/dta.3255
- [3]
- [4]^Vargas-Perez H, Minauro-Sanmiguel F, Ting-A-Kee R, Grieder TE, Méndez-Díaz M, Próspero-García O, van der Kooy D (2024) Rewarding Effects of the Hallucinogen 4-AcO-DMT Administration and Withdrawal in Rats: A Challenge to the Opponent-Process Theory — Neuroscience Letters doi:10.1016/j.neulet.2023.137597